What's a fair revenue multiple though, @hkhf?
One way to estimate that is to back calculate it from an assumed EV/EBITDA multiple and an assumed EBITDA margin. If we assume 8x EV/EBITDA is fair and take an EBITDA margin of 10% (which is roughly double the current normalised numbers: i.e. $0.7m for H1FY22), one arrives at a fair revenue multiple of 0.8x (8 x 0.1).
Those are simply some back-of-the-envelope numbers to get a 40,000-foot view of where we are right now relative to what is fair. Of course, one might argue that the US business is loss-making and that if AMX can get that side of the business under control the EBITDA margin may end up much higher, but for the moment it is circa 6% on a normalised basis ($0.7 x 2 / 22) across the business and so a 10% margin seems fair.
My other reservation here is that the market size is very small being only $80m for MetroMap and only $50m for LiDAR. However, the market size for 3D is much higher to be fair. If we combine the $80m and $50m, we get to a $130m market size. Given AMX has about 15% share versus NEA at 85% share, that suggests a fair value of around ~$19.5m. But, again, that assumes the current status quo remains constant. AMX's opportunity is to steal share off its much larger competitor, Nearmap.
- Forums
- ASX - By Stock
- AMX
- Undervalued / Under radar tech stock
AMX
aerometrex limited
Add to My Watchlist
0.00%
!
21.0¢

Undervalued / Under radar tech stock, page-113
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.94M |
Open | High | Low | Value | Volume |
20.5¢ | 23.5¢ | 20.0¢ | $15.80K | 76.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1070 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 33238 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1070 | 0.230 |
1 | 2500 | 0.210 |
3 | 34074 | 0.205 |
6 | 391485 | 0.200 |
1 | 5128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 33238 | 1 |
0.240 | 3670 | 1 |
0.250 | 5419 | 2 |
0.265 | 4791 | 1 |
0.275 | 29454 | 1 |
Last trade - 15.22pm 27/06/2025 (20 minute delay) ? |
Featured News
AMX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online